YTTRIUM Y-90 TACATUZUMAB TETRAXETAN
UNII GJ2416WK6Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Yttrium Y-90 Tacatuzumab Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GJ2416WK6Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 476413-07-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GJ2416WK6Y

CAS Registry Number

476413-07-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

YTTRIUM Y-90 TACATUZUMAB TETRAXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C48428

National Cancer Institute reference terminology for clinical and research data.

INN ID

8484

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

PP-51

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Yttrium Y-90 Tacatuzumab Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.